![](bg5.png)
as seen in Table 5. As a conclusion, intervention with
public counseling and booklet handouts is effective to
improve the compliance of patients with type 2 DM.
Both Wulandari et al. (2017) and this study used
respondents from primary health care centers in East
Jakarta, but they differed in the model of education.
Public counseling alone also signicantly improves
patient’s adherence to complete the medication.
Taking place in a primary health care center in Greece,
Merakou et al. (2015) state that group-based patient
education with some models for people with type 2
DM is more effective in diabetes self-management
compared with individual education.
Medication adherence is the most important
component in type 2 DM management. It is achievable
by giving routine education to patients to increase
their knowledge about their disease and medication.
Pharmacists can contribute and play a major role in
the assessment of patients’ understanding of the illness
and therapy of DM (Inamdar et al., 2013). Hughes et
al. (2017) explain that there is signicant evidence to
support the role of pharmacists in providing a range of
extensive diabetes care services, from the screening
to the continuous management of the state of the
disease. Furthermore, Supardi and Susyanti (2012)
state that only 10% of the primary health care centers
in Indonesia have pharmacists. The limited number of
pharmacists at primary health care centers inhibits the
provision of personal education by pharmacists to the
patients. Public counseling becomes an alternative
that is effective and cost-efcient.
4 CONCLUSIONS
Educational intervention through public counseling
is signicantly effective to improve medication
adherence in type 2 diabetes mellitus patient.
ACKNOWLEDGMENTS
The authors would like to acknowledge all
pharmacists and other health professionals at Pondok
Kelapa primary health care center in East Jakarta who
were involved in this research.
REFERENCES
American Diabetes Association (ADA), 2003. Treatment
of hypertension in adults with diabetes, Diabetes
Care, 26(suppl 1), pp. S80–S82. doi: 10.2337/
DIACARE.26.2007.S80.
American Diabetes Association (ADA), 2017. Standard of
medical care in diabetes - 2017, Diabetes Care, 40 (sup
1)(January), pp. s4–s128. doi: 10.2337/dc17-S003.
Badan Penelitian dan Pengembangan Kesehatan, 2013.
Riset Kesehatan Dasar (RISKESDAS) 2013, Laporan
Nasional 2013, pp. 1–384. doi: 1 Desember 2013.
Cameron, F., 2006. Standards of Medical Care in Diabetes -
2016, Australian family physician, 35(6), pp. 386–390.
doi: 10.2337/dc14-S014.
Care, M., 2013. Standards of medical care in diabetes - 2013,
Diabetes Care, 36(SUPPL.1). doi: 10.2337/dc13-S011.
Chang, S. A., 2012. Smoking and type 2 diabetes mellitus,
Diabetes and Metabolism Journal, 36(6), pp. 399–403.
doi: 10.4093/dmj.2012.36.6.399.
De Geest, S. and Sabaté, E., 2003. Adherence to long-term
therapies: Evidence for action, European Journal of
Cardiovascular Nursing, 2(4), p. 323. doi: 10.1016/
S1474-5151(03)00091-4.
DiPiro, J. T., Wells, B. G., Schwinghammer, T. L., DiPiro,
C. V., 2015. Pharmacotherapy handbook. Available
at: http://www.loc.gov/catdir/toc/mh023/99073195.
html%5Cnhttp://www.loc.gov/catdir/enhancements/
fy0653/99073195-d.html.
Elsous, A., Radwan, M., Al-Sharif, H., Mustafa, A. A., 2017.
Medications adherence and associated factors among
patients with type 2 diabetes mellitus in the Gaza Strip,
Palestine, Frontiers in Endocrinology, 8(JUN), pp. 1–9.
doi: 10.3389/fendo.2017.00100.
García-Pérez, L.-E., Alvarez, M., Dilla, T., Gil-Guilen, V.,
Orozco-Beltran, D., 2013. Adherence to Therapies in
Patients with Type 2 Diabetes, Diabetes Therapy, 4(2),
pp. 175–194. doi: 10.1007/s13300-013-0034-y.
Gimenes, H., Zanetti, M. and Vanderlei, J., 2009. Factors
related to patient adherence to antidiabetic drug therapy,
Revista latinoam Enfermagem, 17(1), pp. 46–51. doi:
10.1590/S0104-11692009000100008.
Hughes, J. D., Wibowo, Y., Sunderland, B., Hoti, K., 2017.
The role of the pharmacist in the management of type
2 diabetes: current insights and future directions,
Integrated Pharmacy Research and Practice, 6, pp.
15–27. doi: 10.2147/IPRP.S103783.
Inamdar, S. Z., Kulkarni, R. V., Karajgi, S. R., Manvi, F.
V., Ganachari, M. S., Mahendra-Kumar. B. J., 2013.
Medication Adherence in Diabetes Mellitus : An
Overview on Pharmacist Role, American journal of
advanced drug delivery, 1(3), pp. 238–250.
Katzung, B. G. and Trevor, A., 2015. Basic & Clinical
Pharmacology, 13th Edition, Basic and Clinical
Pharmacology.
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas,
L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T.,
Munshi, M. N., Odegard, P. S., Pratley, R. E., Swift,
C. S., 2012. Diabetes in older adults, Diabetes Care,
35(12), pp. 2650–2664. doi: 10.2337/dc12-1801.
Lin, L.-K. Sun, Y., Heng, B H., Chew, D. E. K.,Chong, P.
N., 2017. Medication adherence and glycemic control
among newly diagnosed diabetes patients, BMJ Open
Public Counseling: An Educational Model to Improve Medication Adherence in Type 2 Diabetes Mellitus Patients
75